Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA

  title={Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA},
  author={Charalampos L Karadimas and Penny Greenstein and Carolyn M. Sue and Jeffrey T. Joseph and Kurenai Tanji and Ronald G Haller and Tanja Taivassalo and Mercy M. Davidson and Sara Shanske and Eduardo Bonilla and Salvatore Dimauro},
  pages={644 - 649}
Objective: To elucidate the molecular basis of a mitochondrial myopathy associated with recurrent myoglobinuria and cytochrome c oxidase (COX) deficiency in muscle. Background: Recurrent myoglobinuria is typically seen in patients with inborn errors of carbohydrate or lipid metabolism, the main sources of energy for muscle contraction. Relatively little attention has been directed to defects of the mitochondrial respiratory chain in patients with otherwise unexplained recurrent myoglobinuria… 

Figures and Tables from this paper

Mitochondrial Myopathy and Rhabdomyolysis Associated with a Novel Nonsense Mutation in the Gene Encoding Cytochrome c Oxidase Subunit I

A novel heteroplasmic G6708A nonsense mutation in the mtDNA COI gene encoding COX subunit I in a 30-year-old woman with muscle weakness, pain, fatigue, and one episode of rhabdomyolysis is reported, supporting the concept that COXSubunit I is essential for the assembly of complex IV in the respiratory chain.

A mitochondrial DNA duplication as a marker of skeletal muscle specific mutations in the mitochondrial genome

Ten patients harbouring different mtDNA mutations restricted to skeletal muscle are reported, 5 patients with point mutations and 5 with single deletions, and a 652 bp duplication in the mtDNA control region, which altered the promoter and replication elements is identified.

Mitochondrial myopathy due to novel missense mutation in the cytochrome c oxidase 1 gene

Early onset multisystem mitochondrial disorder caused by a nonsense mutation in the mitochondrial DNA Cytochrome C oxidase II gene

We report the first nonsense mutation (G7896A) in the mtDNA gene for subunit II of cytochrome c oxidase (COX) in a patient with early‐onset multisystem disease and COX deficiency in muscle. The

Childhood onset mitochondrial myopathy and lactic acidosis caused by a stop mutation in the mitochondrial cytochrome c oxidase III gene

It is of interest that pathogenic mutations in mtDNA encoded subunits I-III have been identified whereas no mutations in the 10 nuclear genes are known so far, and numerous mutations in nuclear genes involved in the assembly of COX have been described.

Metabolic consequences of a novel missense mutation of the mtDNA CO I gene.

In vivo investigations of mitochondrial function in saponin-permeabilized muscle fibers of the index patient containing approximately 90% mutated mtDNA showed decreased maximal rates of respiration and an increased sensitivity of fiber respiration to cyanide, supporting the concept of tight COX control of oxidative phosphorylation in skeletal muscle.

Mitochondrial Encephalomyopathies

Several nuclear genes associated with mtDNA maintenance have been found to be associated with mitochondrial disorders since mutations in these genes predispose to multiple mtDNA deletions and/or reduced copy number of mtDNA.



Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA.

The sporadic form of mitochondrial myopathy is associated with somatic mutations in the cytochrome b gene of mtDNA, one cause of the common and often elusive syndrome of exercise intolerance.

Exercise intolerance due to a nonsense mutation in the mtDNA ND4 gene

We report the first molecular defect in an NADH‐dehydrogenase gene presenting as isolated myopathy. The proband had lifelong exercise intolerance but no weakness. A muscle biopsy showed cytochrome c

Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA.

The findings reported here represent only the second case of isolated COX deficiency to be defined at the molecular genetic level and reveal a new mutational mechanism in mitochondrial disease.

A missense mutation of cytochrome oxidase subunit II causes defective assembly and myopathy.

Observations suggest that, in the COX protein, a structural association of COX II with COX I is necessary to stabilize the binding of heme a3 to COX i, the first missense mutation in the mtDNA gene for subunit II of cytochrome c oxidase (COX).

Gene shifting: a novel therapy for mitochondrial myopathy.

Data show that it is possible to reverse the molecular events that led to expression of metabolic myopathy and demonstrate the effectiveness of this form of 'gene shifting' therapy.

A microdeletion in cytochrome c oxidase (COX) subunit III associated with COX deficiency and recurrent myoglobinuria

A 15-bp microdeletion in a highly conserved region of the mitochondrially encoded gene for cytochrome c oxidase (COX) subunit III is identified in a patient with severe isolated COX deficiency and recurrent myoglobinuria, the first case of isolated COx deficiency to be defined at the molecular level.

Cytochrome c Oxidase subunit I microdeletion in a patient with motor neuron disease

An out‐of‐frame mutation of the mitochondrial DNA‐encoded subunit I of cytochrome c oxidase (COX) was discovered during investigation of a severe isolated muscle COX deficiency in a patient with motor neuron‐like degeneration, suggesting that OXPHOS impairment could play a role in the pathogenesis of some MND cases.

Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy.

CoQ10 deficiency is established as a cause of a familial mitochondrial cytopathy and it is suggested that the disease results from a tissue-specific defect of CoQ10 biosynthesis.

A novel mitochondrial tRNA phenylalanine mutation presenting with acute rhabdomyolysis

This is the first case of a mitochondrial tRNA gene point mutation presenting with acute rhabdomyolysis and recurrent myoglobinuria and analysis of single muscle fibers revealed a significantly greater level of mutant mtDNA in COX‐negative fibers.